RANDOMIZED CONTROLLED TRIAL OF POSTOPERATIVE RADIOTHERAPY AND SHORT-TERM TIME-SCHEDULED 5-FLUOROURACIL AGAINST SURGERY ALONE IN THE TREATMENT OF DUKE-B AND DUKE-C RECTAL-CANCER
Km. Tveit et al., RANDOMIZED CONTROLLED TRIAL OF POSTOPERATIVE RADIOTHERAPY AND SHORT-TERM TIME-SCHEDULED 5-FLUOROURACIL AGAINST SURGERY ALONE IN THE TREATMENT OF DUKE-B AND DUKE-C RECTAL-CANCER, British Journal of Surgery, 84(8), 1997, pp. 1130-1135
Background The purpose of the present study was to investigate whether
a 1-month regimen of postoperative radiotherapy combined with 5-fluor
ouracil could reduce the local recurrence rate and improve survival in
patients with Dukes B and C rectal cancer. Methods One hundred and fo
rty-four patients were randomized to surgery alone or surgery combined
with postoperative radiotherapy (46 Gy) and bolus 5-fluorouracil 30 m
in before six of the radiotherapy fractions. One hundred and thirty-si
x patients were eligible. Results The adjuvant treatment was well tole
rated. After an observation time of 4-8 years, patients in the adjuvan
t treatment group had a cumulative local recurrence rate of 12 per cen
t compared with 30 per cent in the group that had surgery only (P = 0.
01). The 5-year recurrence-free and overall survival rate was 64 per c
ent in the adjuvant group compared with 46 per cent (P = 0.01) and 50
per cent (P = 0.05) respectively in the surgery group. The adjusted re
lative risk of recurrence and death for the adjuvant group was 0.48 (9
5 per cent confidence interval 0.28-0.82) and 0.56 (0.33-0.94) respect
ively. Conclusion The 1-month postoperative combination regimen improv
ed treatment results in patients with Dukes B and C rectal cancer, id
terms of local recurrence rate, recurrence-free survival and overall s
urvival, without serious side-effects.